Register entry
OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
1| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8759350 | ABILIFYaripiprazole | use | Mar 2027 |
Enquiry
Common questions
- Is OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC FDA approved?
- OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.